Printer Friendly

CYTRX CORPORATION TO BE TRADED ON NASDAQ NATIONAL MARKET SYSTEM

 CYTRX CORPORATION TO BE TRADED ON NASDAQ NATIONAL MARKET SYSTEM
 NORCROSS, Ga., Dec. 2 /PRNewswire/ -- CytRx Corporation announced today that its Common Stock (symbol CYTR) and Class B Warrants (symbol CYTRZ) will begin trading on the National Market System (NMS) of the National Association of Securities Dealers Automated Quotation Service (NASDAQ) beginning tomorrow, Dec. 3.
 The NASDAQ National Market provides brokers and others with immediate access to the best bid and asked prices and other information about the company's securities throughout the trading day. Those prices are available over more than 190,000 electronic terminals in brokers' offices throughout the United States. Trading data are also distributed widely through wire services for selective dissemination by newspapers and radio and television stations.
 CytRx securities had previously been listed on NASDAQ NMS but were moved to regular NASDAQ in August 1989 due to the company falling below the minimum equity requirement for NMS listing. CytRx recently met the stricter NMS entry requirements by raising $19 million in additional capital through the conversion of 6 million of its Class A Warrants.
 Cytrx Corporation is a biopharmaceutical company engaged in the research and development of therapeutics incorporating copolymers. The company is developing human pharmaceutical products intended for use in the treatment of vascular, immune system and infectious diseases as well as burns. The company is also developing feed additives intended for growth enhancement in food animals, adjuvants for use in both human and veterinary vaccines and is currently marketing Hunter's TiterMax(TM), an immunoadjuvant for use by the basic research community.
 -0- 12/2/91
 /CONTACT: CytRx Corporation public relations, 404-368-9500/
 (CYTR CYTRZ) CO: CytRx Corporation ST: Georgia IN: MTC SU:


CF-TG -- AT002 -- 8234 12/02/91 09:33 EST
COPYRIGHT 1991 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1991 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Dec 2, 1991
Words:286
Previous Article:ALDUS SHIPS PAGEMAKER DATABASE EDITION
Next Article:THE RYLAND GROUP RECORDS FOURTH-QUARTER EARNINGS CHARGE; COMPANY EXPECTS TO REMAIN PROFITABLE FOR QUARTER AND YEAR
Topics:


Related Articles
CYTRX CORPORATION RAISES $19 MILLION THROUGH CONVERSION OF WARRANTS
CYTRX CORPORATION ANNOUNCES REDEMPTION OF CLASS B WARRANTS
CYTRX CORPORATION ANNOUNCES 1991 EARNINGS
CHICAGO BOARD TO LIST CYTRX OPTIONS
CYTRX CORPORATION ANNOUNCES APPOINTMENT OF PRESIDENT AND CEO OF VAXCEL, INC.
CYTRX SAYS RHEOTHRX UNDER CONSIDERATION FOR ISIS-5 TRIAL
CYTRX REPORTS SIGNIFICANT STOCK PRICE INCREASE
CytRx Completes Redemption Of Convertible Debentures
CytRx Securities Delisting Action by Nasdaq Stayed with Scheduled Hearing.
CytRx Regains Full Compliance With Nasdaq Listing Requirements.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters